Author

P M Czerniak

Observed names: P. Czerniak, P. M. CZERNIAK, Phil Czerniak

Observed institutions: DuPont (United States), The University of Texas System, The University of Texas at San Antonio Health Science Center

OpenAlex ID: A5111989295

Effects of Modulation of Basic Fibroblast Growth Factor on Tumor Growth In Vivo

1993 · J. L. Gross, W. F. Herblin, et al. · JNCI Journal of the National Cancer Institute · 105

Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors.

1999 · J S Kerr, R S Wexler, et al. · PubMed · 99

Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.

1994 · R J McRipley, P E Burns-Horwitz, et al. · PubMed · 40

Thiazolidines and Aminoalkylthiosulfuric Acids as Protecting Agents against Ionizing Radiation

1961 · A. Kaluszyner, P. Czerniak, et al. · Radiation Research · 25

XB596, a promising bis-naphthalimide anti-cancer agent

1993 · S F Chen, D L Behrens, et al. · Anti-Cancer Drugs · 16

Identification and Characterization of INCB9471, an Allosteric Noncompetitive Small-Molecule Antagonist of C-C Chemokine Receptor 5 with Potent Inhibitory Activity against Monocyte Migration and HIV-1 Infection

2011 · Niu Shin, Kim Solomon, et al. · Journal of Pharmacology and Experimental Therapeutics · 15

ChemInform Abstract: The Synthesis and Antitumor Evaluation of Unsymmetrical Bis‐imides.

1997 · R. J. CHERNEY, S. G. SWARTZ, et al. · ChemInform

Works count: 7

Citation count: 300

H-index: 6

I10-index: 6